During the past decade, Betsi Cadwaladr University Health Board, conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Betsi Cadwaladr University Health Board," #1 sponsor was "Bangor University" with 1 trials, followed by "Cambridge University Hospitals NHS Foundation Trust" with 1 trials sponsored, "King's College Hospital NHS Trust" with 1 trials sponsored, "Newcastle-upon-Tyne Hospitals NHS Trust" with 1 trials sponsored and "Queen Mary University of London" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Betsi Cadwaladr University Health Board," #1 collaborator was "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Addenbrookes Charitable Trust" with 1 trials as a collaborator, "Alder Hey Children's NHS Foundation Trust" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Cancer Research UK" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Betsi Cadwaladr University Health Board," are "Anterior Cruciate Ligament Injury" (1 trials), "Covid19" (1 trials), "Human Papilloma Virus" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Neurological Disorder" (1 trials). Many other conditions were trialed in "Betsi Cadwaladr University Health Board," in a lesser frequency.

Most popular intervention types in "Betsi Cadwaladr University Health Board," are "Drug" (3 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AZD5363" (1 trials), "Adjuvant therapies" (1 trials), "Carbon dioxide laser" (1 trials) and "Ciclesonide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Betsi Cadwaladr University Health Board," are 5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Betsi Cadwaladr University Health Board,". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Betsi Cadwaladr University Health Board,, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Betsi Cadwaladr University Health Board,, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".